ASA Vice President for Scientific Affairs Arnold Berry, MD, MPH, and ASA Director of Practice Management, Quality and Regulatory Affairs Jason Byrd, JD, participated on panels during the meeting. The workshop was intended to provide stakeholders with additional information and insights around the causes and impact of drug shortages.
Throughout the day, the shortages of anesthesia and oncology drugs were the most frequently mentioned. Dr. Berry presented the findings of the ASA Drug Shortages survey in his presentation and discussed the additional healthcare costs resulting from drug shortages.
Related Articles on Anesthesia:
Patients Protest Use of Propofol Following Michael Jackson’s Death, Physicians Say
Federal Government Scrutinizes Drug Shortages With ASA Backing
Drug Firm President Asks Florida Governor Not to Use Pentobarbital in Execution
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.